Researchers improve classification of pancreatic cancer to better predict patient outcomes

by Katie Sullivan,University of TorontoSangeetha Kalimuthu, an assistant professor of laboratory medicine and pathobiology at U of T and a gastrointestinal pathologist at UHN, is the co-author o

Updated on: June 15,2024

Researchers improve classification of pancreatic cancer to better predict patient outcomes

by Katie Sullivan,University of TorontoSangeetha Kalimuthu, an assistant professor of laboratory medicine and pathobiology at U of T and a gastrointestinal pathologist at UHN, is the co-author o

Updated on:June 15,2024

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

Updated on: January 11,2024

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

Updated on:January 11,2024

Researchers publish preclinical data on new drug combination to treat neuroblastoma

by Texas Tech UniversityTTUHSC's C. Patrick Reynolds, M.D., Ph.D., recently published preclinical data on a new drug combination to treat neuroblastoma. Credit: TTUHSCNeuroblastoma is the mos

Updated on: June 15,2024

Researchers publish preclinical data on new drug combination to treat neuroblastoma

by Texas Tech UniversityTTUHSC's C. Patrick Reynolds, M.D., Ph.D., recently published preclinical data on a new drug combination to treat neuroblastoma. Credit: TTUHSCNeuroblastoma is the mos

Updated on:June 15,2024

Testing method could point thousands more cancer patients to lifesaving treatment

byUniversity of OklahomaDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHNot all cancer therapies are successful, but cancer researchers increa

Updated on: March 27,2024

Testing method could point thousands more cancer patients to lifesaving treatment

byUniversity of OklahomaDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHNot all cancer therapies are successful, but cancer researchers increa

Updated on:March 27,2024

Financial toxicity from breast cancer treatment is common

by Lori SolomonWorldwide, breast cancer treatment is associated with substantial financial toxicity, according to a systematic review and meta-analysis published online Feb. 8 inJAMA Network Ope

Updated on: January 03,2024

Financial toxicity from breast cancer treatment is common

by Lori SolomonWorldwide, breast cancer treatment is associated with substantial financial toxicity, according to a systematic review and meta-analysis published online Feb. 8 inJAMA Network Ope

Updated on:January 03,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on: April 07,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on:April 07,2024

Heading off financial harms in cancer patients

by Columbia UniversityCredit: Pixabay/CC0 Public DomainA screening tool can quickly identify cancer patients at risk of financial toxicity, new findings from Columbia Nursing researchers show.Mos

Updated on: March 30,2024

Heading off financial harms in cancer patients

by Columbia UniversityCredit: Pixabay/CC0 Public DomainA screening tool can quickly identify cancer patients at risk of financial toxicity, new findings from Columbia Nursing researchers show.Mos

Updated on:March 30,2024

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on: March 12,2024

Scientists discover sweet spot of activity in immune system key to fighting cancer

by University of SouthamptonConcentrated CD40 receptions (grey wavy lines) on the immune cell surface. Credit: University of SouthamptonScientists at the University of Southampton have shown how

Updated on:March 12,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024

Loss of cilia leads to melanoma

by University of ZurichPigment cells (blue/green) with cilium (light green with red base). Credit: Daniel Zingg, Netherlands Cancer InstituteMost cells in the human body have a cilium, a slender

Updated on: March 06,2024

Loss of cilia leads to melanoma

by University of ZurichPigment cells (blue/green) with cilium (light green with red base). Credit: Daniel Zingg, Netherlands Cancer InstituteMost cells in the human body have a cilium, a slender

Updated on:March 06,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on: February 01,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on:February 01,2024

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit

Updated on: November 09,2024

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit

Updated on:November 09,2024